ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975